LOXL2 and esophageal cancer: High level expression of full-length LOXL2, as well as its L2Δ13 isoform, promotes cell migration and invasion of esophageal cancer cells in vitro and in vivo, which is further linked to tumor metastasis and poor clinical outcome of esophageal cancer patients [16,21].